Flu data used to determine vaccine effectiveness

(Medical Xpress)—Armed with data on vaccine effectiveness from five study monitoring sites, including one at the University of Michigan School of Public Health, the Centers for Disease Control is renewing the call for everyone over the age of six months to get a flu vaccine.

The CDC says this year's vaccine on average is 62 percent effective against influenza, a number consistent with clinical trials and historic profiles.

"The vaccine is giving considerable protection," said Dr. Arnold Monto, professor of epidemiology whose lab at U-M is part of the U.S. Effectiveness (Flu VE) Network. "It may also modify the severity of illness. Taking the vaccine probably also means you won't transmit as much to others, allowing you to protect your neighbors and your household, even if you do get the flu."

Monto, a world-renowned flu expert who has studied transmission of influenza in communities for years, and colleague Allison Aiello, associate professor of epidemiology, are working on a study in U-M residence halls on the effect of voluntary isolation on transmission.

The CDC weekly report also calls for the use of antiviral medications. Prescription drugs like Tamiflu and can be used to reduce symptoms and shorten the duration of the flu by as much as 1-2 days, according to the CDC. These medications typically are recommended for people who are at high risk for complications from the flu: the very young or old, those with compromised immune systems or serious .

"My feeling is that antivirals should be considered in any severe case, especially for those in a high-risk category," Monto said.

More information: Read the CDC weekly Influenza report at: www.cdc.gov/mmwr/preview/mmwrh… ?s_cid=mm62e0111a1_e

add to favorites email to friend print save as pdf

Related Stories

No Excuses: Flu vaccination myths addressed

Oct 12, 2012

Flu season is here. According to the Centers for Disease Control and Prevention, each year five to 20 percent of Americans get the flu and more than 200,000 people are hospitalized due to flu-related complications. Flu season ...

FDA approves first 4-in-1 flu vaccine

Feb 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Nanopatch to help WHO battle polio

8 hours ago

The World Health Organisation's (WHO) battle against polio has a new weapon after joining forces with Vaxxas, the biotechnology company responsible for developing revolutionary vaccine delivery method the Nanopatch.

User comments